J&J Fights Attys' Pursuit Of Confidential Risperdal Docs

Law360, Philadelphia (December 18, 2013, 6:05 PM EST) -- A Johnson & Johnson unit argued in Pennsylvania court Monday that the public release of discovery documents in a slew of state product liability cases, pending as part of a mass tort program, over the antipsychotic drug Risperdal would prejudice the drugmaker.

Janssen Pharmaceuticals Inc. argued that the plaintiffs' counsel were requesting the release of the documents as part of a coordinated smear campaign, according to a brief.

The plaintiffs — whose complaint claims Risperdal caused gynecomastia, or abnormal growth of breast tissue in adolescent boys...
To view the full article, register now.